Drug-labels.com

Teva-Febuxostat: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
80 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Teva-Febuxostat

ABOUT THIS MEDICATION

What the medication is used for:

TEVA-FEBUXOSTAT is used to lower uric acid levels in adult patients with gout. It is used when allopurinol has not worked well enough or when allopurinol is not right for you.

What it does:

TEVA-FEBUXOSTAT contains febuxostat which is a xanthine oxidase (XO) inhibitor. TEVA-FEBUXOSTAT works to lower the uric acid in the blood by selectively inhibiting XO involved in uric acid formation. The normal uric acid level should be lower than 360 mcmol/L (6.0 mg/dL).

When it should not be used:

Do not take TEVA-FEBUXOSTAT if you are allergic to febuxostat or any other ingredients in TEVA-FEBUXOSTAT.

Do not take TEVA-FEBUXOSTAT if you take:

  • azathioprine
  • mercaptopurine

What the medicinal ingredient is:

Febuxostat (as febuxostat hemihydrate)

What the nonmedicinal ingredients are:

Colloidal silica anhydrous, croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate and microcrystalline cellulose. The film coating contains iron oxide yellow, polyethylene glycol, polyvinyl alcohol, titanium dioxide, and talc.

What dosage forms it comes in:

Tablets. Each tablet contains 80 mg febuxostat (as febuxostat hemihydrate).

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

  • A higher number of deaths was seen in a study of gout patients with heart problems who were treated with febuxostat. This was compared to patients treated with allopurinol.
  • Your doctor will consider the side effects and benefits of TEVA-FEBUXOSTAT before and during your treatment. TEVA-FEBUXOSTAT should only be used when
  • allopurinol has not worked well enough or when allopurinol is not right for you.

TEVA-FEBUXOSTAT treatment should only be started when the acute attack of gout has subsided.

Whenever you start medicines that can lower uric acid levels, like TEVA-FEBUXOSTAT, gout may flare up. This is due to the body’s efforts to get rid of uric acid crystals from the joints. However over time, reducing your uric acid level can decrease your gout flares. Your healthcare professional may add other medicines to help prevent or manage flares while taking TEVA-FEBUXOSTAT.

Heart attacks, strokes and heart-related deaths have been reported. You should not use TEVA-FEBUXOSTAT if you have heart problems, such as heart failure or have had a stroke or heart attack.

Mild increases in liver function tests were reported in some patients taking febuxostat. Your healthcare professional may do blood tests to check your liver function.

Some serious skin and allergic reactions such as rash, skin reddening, pain, swelling or blistering of lips, eyes or mouth, skin peeling and flu-like symptoms have been reported in patients taking febuxostat. If you get these symptoms, your doctor may stop your treatment until your skin condition improves. Patients who had previous reactions to allopurinol are at greater risk for these skin conditions.

BEFORE you use TEVA-FEBUXOSTAT talk to your doctor or pharmacist if you:

  • have taken allopurinol. Tell your doctor what happened to you while you were taking it.
  • have a history of liver or kidney problems.
  • have heart disease, heart problems or had a stroke.
  • are pregnant, breastfeeding or plan to become pregnant, or plan to breast-feed. It is not known if febuxostat will harm your unborn baby. It is also unknown if febuxostat passes into your breast milk.

  • Have ones of the following hereditary diseases:

    • Galactose intolerance
    • Lapp lactase deficiency
    • Glucose-galactose malabsorption

This is because TEVA-FEBUXOSTAT contains lactose.

It is not known if febuxostat is safe and effective in children under 18 years of age.

INTERACTIONS WITH THIS MEDICATION

Do not take TEVA-FEBUXOSTAT if you take:

  • azathioprine
  • mercaptopurine

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. TEVA-FEBUXOSTAT may affect the way other medicines work, and other medicines may affect how TEVA-FEBUXOSTAT works.

Know the medicines you take. Keep a list of them and show it to your healthcare provider and pharmacist when you get a new medicine.

PROPER USE OF THIS MEDICATION

Usual adult dose:

The recommended dose of TEVA-FEBUXOSTAT is one 80 mg tablet once daily.

  • Take TEVA-FEBUXOSTAT exactly as your healthcare provider tells you to take it.
  • TEVA-FEBUXOSTAT can be taken with or without food.

  • TEVA-FEBUXOSTAT can be taken with antacids.
  • It is important not to stop taking your TEVA-FEBUXOSTAT without first consulting with your healthcare provider even if you have a flare.
  • Your healthcare provider may do certain tests while you take TEVA-FEBUXOSTAT.

Overdose:

If you think you have taken too much TEVA-FEBUXOSTAT, contact your healthcare professional, hospital emergency department or the regional Poison Control Centre, immediately even if there are no symptoms.

Missed Dose:

If you miss a dose of TEVA-FEBUXOSTAT, take your TEVA-FEBUXOSTAT as soon as you remember. If it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects of TEVA-FEBUXOSTAT include:

  • liver problems
  • diarrhea
  • rash
  • nausea
  • dizziness

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
UncommonAllergic Reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing√

Serious Skin

Reaction (Stevens-Johnson Syndrome, Toxic Epidermal

Necrolysis, DRESS [drug rash with eosinophilia and systemic symptoms]): any combination of red itchy rash with blisters and peeling of the skin and /or of the lips, eyes, mouth, nasal passages or genitals. It often goes with fever, chills, headache, cough, body aches or joint pain. You may have less or dark urine, yellow skin or eyes.

√
Stroke: loss of feeling or movement on one side of the body, slurring of speech, sudden blurry vision, or severe headache.√
Heart problems: chest pain, shortness of breath, dizziness, fainting or feeling light-headed, rapid or irregular heart beat.√

This is not a complete list of side effects. For any unexpected effects while taking TEVA-FEBUXOSTAT, contact your doctor or pharmacist.

HOW TO STORE IT

Store TEVA-FEBUXOSTAT between 15°C - 30°C.

Keep TEVA-FEBUXOSTAT and all medicines out of the reach of children.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about TEVA-FEBUXOSTAT:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada.html); or by contacting the sponsor,
  • Teva Canada Limited by:

    Phone: 1-800-268-4127 ext. 3

    Email: druginfo@tevacanada.com; or

    Fax: 1-416-335-4472

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

Canada, M1B 2K9

www.tevacanada.com

Last revised: January 27, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02466198

Revision date stated in the text: January 27, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Teva-Febuxostat

Rx or OTC
Prescription (Rx)?
DIN 02466198
Schedule(s) PRESCRIPTION
Active ingredient(s) Febuxostat (febuxostat hemihydrate) 80 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. M Musculo-skeletal system drugs
    1. M04 Antigout preparations
      1. M04A Antigout preparations
        1. M04AA Preparations inhibiting uric acid production
          1. M04AA03 Febuxostat
Company TEVA CANADA LIMITED
Current status Marketed
Current status date November 28, 2019

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.